Head-to-head comparison of single agent (SA) plinabulin (Plin) versus pegfilgrastim (Peg) for the prevention of chemotherapy-induced neutropenia (CIN) in the phase 3 trial PROTECTIVE-1. Blayney, D. W., Shi, Y., Bondarenko, I., Ogenstad, S., Zhang, Q., Du, L., Huang, L., Mohanlal, R. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.547

View details for Web of Science ID 000708120600059